Share on LinkedInShare on LinkedIn

ARTICLE · 19 FEBRUARY 2019

TTAB Dismisses 2(d) Opposition To "M" Mark For Medication Costing Software

Wolf Greenfield & Sacks
Wolf Greenfield & Sacks
Contributor
Wolf Greenfield & Sacks

Wolf Greenfield & Sacks

Wolf, Greenfield is one of the 10 largest law firms in the United States devoted exclusively to...

View firm profile
Explore more from Wolf Greenfield & Sacks

The Board dismissed this Section 2(d) opposition to registration of the mark shown below left, for software "for providing information to medical personnel and patients regarding the cost of a patient's prescription medication ...

United StatesIntellectual Property

The Board dismissed this Section 2(d) opposition to registration of the mark shown below left, for software "for providing information to medical personnel and patients regarding the cost of a patient's prescription medication taking into account that patient's insurance coverage," finding that opposer had failed to prove a likelihood of confusion with the two registered marks shown below right, for various medical services and publications. H. Lee Moffitt Cancer Center and Research Institute, Inc. v. Milligram, Inc., Opposition No. 91228243 (February 11, 2018) [not precedential] (Opinion by Judge Marc A. Bergsman).

Goods and Services: Opposer Moffitt failed to proved that its goods and services are related to applicant's software. Although "intuitively the 'evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases' should have a connection to pharmacy services," applicant's description of goods and services does not

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from